In line with these reports, our data revealed that administration of MCC950 dramatically reduced NLRP3, IL-1β, IL-6, and TNF-α expression in the brain of NEC mice, accompanied by the decrease of activated microglia and astrocytes, thus resulting in profound improvement of acute brain damage in NEC. This evidence concerns the gene NLRP3 and necrotizing enterocolitis.